Tff Pharmaceuticals Stock Performance
| TFFP Stock | USD 0.34 0.03 9.68% |
The entity has a beta of 1.28, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Tff Pharmaceuticals will likely underperform. At this point, Tff Pharmaceuticals has a negative expected return of -1.33%. Please make sure to validate Tff Pharmaceuticals' value at risk, as well as the relationship between the daily balance of power and period momentum indicator , to decide if Tff Pharmaceuticals performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Tff Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's technical and fundamental indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors. ...more
Last Split Factor 1:25 | Last Split Date 2023-12-19 |
1 | TFF Pharmaceuticals enters pact for dry powder mRNA-based Covid treatment | 09/11/2024 |
2 | Acquisition by Rocamboli Stephen of 3165 shares of Tff Pharmaceuticals subject to Rule 16b-3 | 10/15/2024 |
3 | ARMISTICE CAPITAL, LLC Acquires Shares in TFF Pharmaceuticals Inc | 11/15/2024 |
4 | TFF Pharmaceuticals, Inc. Announces Chief Financial Officer Changes - Marketscreener.com | 11/20/2024 |
| Begin Period Cash Flow | 16.6 M |
Tff |
Tff Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest 187.00 in Tff Pharmaceuticals on September 1, 2024 and sell it today you would lose (153.00) from holding Tff Pharmaceuticals or give up 81.82% of portfolio value over 90 days. Tff Pharmaceuticals is currently does not generate positive expected returns and assumes 12.3621% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Tff, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Tff Pharmaceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Tff Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Tff Pharmaceuticals, and traders can use it to determine the average amount a Tff Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1079
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | TFFP |
Estimated Market Risk
| 12.36 actual daily | 96 96% of assets are less volatile |
Expected Return
| -1.33 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Tff Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tff Pharmaceuticals by adding Tff Pharmaceuticals to a well-diversified portfolio.
Tff Pharmaceuticals Fundamentals Growth
Tff Stock prices reflect investors' perceptions of the future prospects and financial health of Tff Pharmaceuticals, and Tff Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Tff Stock performance.
| Return On Equity | -2.14 | ||||
| Return On Asset | -1.06 | ||||
| Operating Margin | (6.09) % | ||||
| Current Valuation | (1.06 M) | ||||
| Shares Outstanding | 4.44 M | ||||
| Price To Book | 0.48 X | ||||
| Price To Sales | 1.25 X | ||||
| Revenue | 733.87 K | ||||
| Gross Profit | (21.21 M) | ||||
| EBITDA | (20.74 M) | ||||
| Net Income | (21.24 M) | ||||
| Cash And Equivalents | 13.15 M | ||||
| Cash Per Share | 0.51 X | ||||
| Total Debt | 115.25 K | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 8.18 X | ||||
| Book Value Per Share | 4.04 X | ||||
| Cash Flow From Operations | (16.04 M) | ||||
| Earnings Per Share | (5.50) X | ||||
| Market Capitalization | 1.5 M | ||||
| Total Asset | 12.03 M | ||||
| Retained Earnings | (118.33 M) | ||||
| Working Capital | 5.16 M | ||||
About Tff Pharmaceuticals Performance
Assessing Tff Pharmaceuticals' fundamental ratios provides investors with valuable insights into Tff Pharmaceuticals' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Tff Pharmaceuticals is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.77) | (1.85) | |
| Return On Capital Employed | (2.28) | (2.17) | |
| Return On Assets | (1.77) | (1.85) | |
| Return On Equity | (2.22) | (2.11) |
Things to note about Tff Pharmaceuticals performance evaluation
Checking the ongoing alerts about Tff Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Tff Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Tff Pharmaceuticals generated a negative expected return over the last 90 days | |
| Tff Pharmaceuticals has high historical volatility and very poor performance | |
| Tff Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Tff Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 733.87 K. Net Loss for the year was (21.24 M) with loss before overhead, payroll, taxes, and interest of (21.21 M). | |
| Tff Pharmaceuticals currently holds about 13.15 M in cash with (16.04 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.51, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Tff Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: TFF Pharmaceuticals, Inc. Announces Chief Financial Officer Changes - Marketscreener.com |
- Analyzing Tff Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Tff Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Tff Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Tff Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Tff Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Tff Pharmaceuticals' stock. These opinions can provide insight into Tff Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Tff Stock Analysis
When running Tff Pharmaceuticals' price analysis, check to measure Tff Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tff Pharmaceuticals is operating at the current time. Most of Tff Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tff Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tff Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tff Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.